<!DOCTYPE html>
<html lang="en">
<head>        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">    <link
        rel="stylesheet"
        href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css"
        integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm"
        crossorigin="anonymous"
    />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/c3/0.6.12/c3.min.css"/>
    <style>
        h2 {
            margin-top: 35px;
        }

        html, body {
            height: 100%;
        }

        body {
            display: flex;
            flex-flow: column;
        }

        .footer {
            margin-top: auto;
            padding-top: 1em;
            background-color: #f5f5f5;
        }
    </style>    <title>RADAEVA_RESPONSE_TO_IFNA1_UP</title></head>

<body>
<nav class="navbar navbar-expand-lg navbar-light bg-light">
    <span class="navbar-brand">
        Molecular Signatures Database
    </span>
</nav>

<div class="container" style="margin-top: 50px; margin-bottom: 50px">
<div class="card">
        <div class="card-header">
            RADAEVA_RESPONSE_TO_IFNA1_UP
        </div>
        <div class="card-body">
                <p>BACKGROUND &amp; AIMS: Interferon (IFN)-alpha therapy is currently the primary choice for viral hepatitis and a promising treatment for hepatocellular carcinoma (HCC). Primary mouse and rat hepatocytes respond poorly to IFN-alpha stimulation. Thus, it is very important to examine the IFN-alpha signal pathway in primary human hepatocytes. METHODS: The IFN-alpha-activated signals and genes in primary human hepatocytes and hepatoma cells were examined by Western blotting and microarray analyses. RESULTS: Primary human hepatocytes respond very well to IFN-alpha stimulation as shown by activation of multiple signal transducer and activator of transcription factor (STAT) 1, 2, 3, 5, and multiple genes. The differential response to IFN-alpha stimulation in primary human and mouse hepatocytes may be caused by expression of predominant functional IFN-alpha receptor 2c (IFNAR2c) in primary human hepatocytes vs. expression of predominant inhibitory IFNAR2a in mouse hepatocytes. Microarray analyses of primary human hepatocytes show that IFN-alpha up-regulates about 44 genes by over 2-fold and down-regulates about 9 genes by 50%. The up-regulated genes include a variety of antiviral and tumor suppressors/proapoptotic genes. The down-regulated genes include c-myc and c-Met, the hepatocyte growth factor (HGF) receptor. Down-regulation of c-Met is caused by IFN-alpha suppression of the c-Met promoter through down-regulation of Sp1 binding and results in attenuation of HGF-induced signals and cell proliferation. CONCLUSIONS: IFN-alpha directly targets human hepatocytes, followed by activation of multiple STATs and regulation of a wide variety of genes, which may contribute to the antiviral and antitumor activities of IFN-alpha in human liver.</p>
            <dl>
                <dt>Local Unique Identifier</dt>
                <dd><a href="https://bioregistry.io/msigdb:M13763">M13763</a>
                </dd>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            in taxon (<code>RO:0002162</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/NCBITaxon:9606">NCBITaxon:9606</a></li>
                        </ol>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            has part (<code>BFO:0000051</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/ncbigene:7323">ncbigene:7323</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1027">ncbigene:1027</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6772">ncbigene:6772</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3133">ncbigene:3133</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:596">ncbigene:596</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8743">ncbigene:8743</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:9246">ncbigene:9246</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8519">ncbigene:8519</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:354">ncbigene:354</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:811">ncbigene:811</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3627">ncbigene:3627</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3430">ncbigene:3430</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10410">ncbigene:10410</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:103">ncbigene:103</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5982">ncbigene:5982</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3659">ncbigene:3659</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3134">ncbigene:3134</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2537">ncbigene:2537</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:672">ncbigene:672</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:6373">ncbigene:6373</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3429">ncbigene:3429</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:684">ncbigene:684</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:581">ncbigene:581</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5245">ncbigene:5245</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10561">ncbigene:10561</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4600">ncbigene:4600</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1870">ncbigene:1870</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3959">ncbigene:3959</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8574">ncbigene:8574</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:11068">ncbigene:11068</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:836">ncbigene:836</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8651">ncbigene:8651</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:51588">ncbigene:51588</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:4599">ncbigene:4599</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:203068">ncbigene:203068</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5359">ncbigene:5359</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:7412">ncbigene:7412</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:23378">ncbigene:23378</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10608">ncbigene:10608</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10581">ncbigene:10581</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:9636">ncbigene:9636</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:10964">ncbigene:10964</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5720">ncbigene:5720</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3595">ncbigene:3595</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3107">ncbigene:3107</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3665">ncbigene:3665</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5588">ncbigene:5588</a></li>
                        </ol>
                    </dt>
            </dl>
            <span class="badge badge-warning">Term generation via PyOBO is currently under construction</span>
            <blockquote>
                Term(reference=Reference(prefix=&#39;msigdb&#39;, identifier=&#39;M13763&#39;, name=&#39;RADAEVA_RESPONSE_TO_IFNA1_UP&#39;), definition=&#39;BACKGROUND &amp; AIMS: Interferon (IFN)-alpha therapy is currently the primary choice for viral hepatitis and a promising treatment for hepatocellular carcinoma (HCC). Primary mouse and rat hepatocytes respond poorly to IFN-alpha stimulation. Thus, it is very important to examine the IFN-alpha signal pathway in primary human hepatocytes. METHODS: The IFN-alpha-activated signals and genes in primary human hepatocytes and hepatoma cells were examined by Western blotting and microarray analyses. RESULTS: Primary human hepatocytes respond very well to IFN-alpha stimulation as shown by activation of multiple signal transducer and activator of transcription factor (STAT) 1, 2, 3, 5, and multiple genes. The differential response to IFN-alpha stimulation in primary human and mouse hepatocytes may be caused by expression of predominant functional IFN-alpha receptor 2c (IFNAR2c) in primary human hepatocytes vs. expression of predominant inhibitory IFNAR2a in mouse hepatocytes. Microarray analyses of primary human hepatocytes show that IFN-alpha up-regulates about 44 genes by over 2-fold and down-regulates about 9 genes by 50%. The up-regulated genes include a variety of antiviral and tumor suppressors/proapoptotic genes. The down-regulated genes include c-myc and c-Met, the hepatocyte growth factor (HGF) receptor. Down-regulation of c-Met is caused by IFN-alpha suppression of the c-Met promoter through down-regulation of Sp1 binding and results in attenuation of HGF-induced signals and cell proliferation. CONCLUSIONS: IFN-alpha directly targets human hepatocytes, followed by activation of multiple STATs and regulation of a wide variety of genes, which may contribute to the antiviral and antitumor activities of IFN-alpha in human liver.&#39;, provenance=[Reference(prefix=&#39;pubmed&#39;, identifier=&#39;11910354&#39;, name=None)], relationships=defaultdict(&lt;class &#39;list&#39;&gt;, {TypeDef(reference=Reference(prefix=&#39;RO&#39;, identifier=&#39;0002162&#39;, name=&#39;in taxon&#39;), comment=None, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=None, holds_over_chain=None): [Reference(prefix=&#39;NCBITaxon&#39;, identifier=&#39;9606&#39;, name=&#39;Homo sapiens&#39;)], TypeDef(reference=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000051&#39;, name=&#39;has part&#39;), comment=&#39;Inverse of part_of&#39;, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000050&#39;, name=&#39;part of&#39;), holds_over_chain=None): [Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;7323&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1027&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6772&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3133&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;596&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8743&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;9246&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8519&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;354&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;811&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3627&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3430&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10410&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;103&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5982&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3659&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3134&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2537&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;672&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;6373&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3429&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;684&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;581&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5245&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10561&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4600&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1870&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3959&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8574&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;11068&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;836&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8651&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;51588&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;4599&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;203068&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5359&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;7412&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;23378&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10608&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10581&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;9636&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;10964&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5720&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3595&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3107&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3665&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5588&#39;, name=None)]}), properties=defaultdict(&lt;class &#39;list&#39;&gt;, {&#39;category_code&#39;: [&#39;C2&#39;], &#39;sub_category_code&#39;: [&#39;CGP&#39;], &#39;contributor&#39;: [&#39;Yujin Hoshida&#39;], &#39;exact_source&#39;: [&#39;Table 1&#39;]}), parents=[], synonyms=[], xrefs=[], alt_ids=[], namespace=None, is_obsolete=False)
            </blockquote>
        </div>
    </div></div>

<footer class="footer">
    <p class="small text-center text-muted">
        Generated with PyOBO
    </p>
</footer>

<script src="https://code.jquery.com/jquery-3.2.1.slim.min.js"
        integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN"
        crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js"
        integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl"
        crossorigin="anonymous"></script></body>
</html>